Brandon BioCatalyst has created an ecosystem that supports our member institutes, their researchers, entrepreneurs, and our portfolio companies and their teams through all stages of development and commercialisation.
Funds dedicated to supporting the development and commercialisation of early to late-stage medical technologies
Access to risk-tolerant and patient investment capital to support the development of promising technologies.
Through our due diligence process, we access resources to help inform and guide the development of your assets. Through Brandon BioCatalyst, you also have access to the resources and capabilities of more than 50 medical research organisations and hospitals across Australia and New Zealand, as well as an international network of expert advisors.
Funding comes from some of Australia’s largest and most successful superannuation funds, ensuring that your products have access to sufficient capital to support their development.